MILLENIUM PHARMACEUTICALS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MILLENIUM PHARMACEUTICALS, INC..The latest application filed is for "human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor".

Company Profile

4.25.6

MILLENIUM PHARMACEUTICALS, INC. - Cambridge MA
Millenium Pharmaceuticals, Inc.; - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aurora kinase inhibitors for inhibiting mitotic progression Grant 10,836,766 - Claiborne , et al. November 17, 2	2020-11-17
Boronate ester compounds and pharmaceutical compositions thereof Grant 10,604,538 - Elliott , et al.	2020-03-31
Heterocyclic compounds useful as PDK1 inhibitors Grant 10,030,016 - Arndt , et al. July 24, 2	2018-07-24
Aurora kinase inhibitors for inhibiting mitotic progression Grant 9,765,076 - Claiborne , et al. September 19, 2	2017-09-19
Prophylactic or therapeutic method for Sjogren's syndrome Grant 8,815,887 - Suzuki , et al. August 26, 2	2014-08-26
Human Diacylglycerol Acyltransferase 2 (dgat2) Family Members And Uses Therefor App 20140010799 - Gimeno; Ruth E. ; et al.	2014-01-09
Inhibitors Of E1 Activating Enzymes App 20120258927 - Langston; Steven P. ; et al.	2012-10-11
Compositions and methods for inhibiting TGF-.beta. Grant 7,943,640 - Pandey , et al. May 17, 2	2011-05-17
Methods of diagnosing and treating cancer Grant 7,771,953 - Ross August 10, 2	2010-08-10
ACTR-1, a novel human acyltransferase and uses thereof App 20100009384 - Kapeller-Libermann; Rosana ; et al.	2010-01-14
Method of acylating maytansinol with chiral amino acids Grant 7,598,375 - Ho , et al. October 6, 2	2009-10-06
Pharmaceutical salts and polymorphs of a factor Xa inhibitor Grant 7,598,276 - Grant , et al. October 6, 2	2009-10-06
Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor Grant 7,527,962 - Gimeno , et al. May 5, 2	2009-05-05
Molecules of the card-related protein family and uses thereof Grant 7,452,967 - Bertin November 18, 2	2008-11-18
Proteasome inhibitors Grant 7,442,830 - Olhava , et al. October 28, 2	2008-10-28
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer Grant 7,361,511 - Monahan , et al. April 22, 2	2008-04-22
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer Grant 7,125,663 - Schlegel , et al. October 24, 2	2006-10-24
Methods of using the OB receptor antibodies to treat bodyweight disorders Grant 6,977,240 - Tartaglia , et al. December 20, 2	2005-12-20
High-throughput formation, identification and analysis of diverse solid forms App 20050191614 - Cima, Michael J. ; et al.	2005-09-01
Compounds and methods for the modulation of CD154 Grant 6,861,504 - Phillips , et al. March 1, 2	2005-03-01
FOHY03 polypeptides Grant 6,825,320 - Shyjan November 30, 2	2004-11-30
25312, a novel human agmatinase-like homolog Grant 6,642,039 - Cook , et al. November 4, 2	2003-11-04
Essential bacterial genes and their use Grant 6,627,747 - Fritz , et al. September 30, 2	2003-09-30
Novel fibroblast growth factors and therapeutic and diagnostic uses therefor App 20030022170 - Khodadoust, Mehran Mohamad	2003-01-30
Method of inhibiting cell function associated with CCR2 by anti-CCR2 amino-terminal domain antibodies Grant 6,448,021 - LaRosa September 10, 2	2002-09-10
RGS-containing molecules and uses thereof Grant 6,410,240 - Hodge , et al. June 25, 2	2002-06-25
Molecules of the TNF receptor superfamily and uses therefor Grant 6,194,151 - Busfield February 27, 2	2001-02-27
Aspergillus fumigatus auxotrophs, auxotrophic markers and polynucleotides encoding same Grant 6,090,581 - Gavrias July 18, 2	2000-07-18
Conservin compositions Grant 6,031,076 - Falb , et al. February 29, 2	2000-02-29
Genes encoding proteins that interact with the tub protein Grant 5,955,306 - Gimeno , et al. September 21, 1	1999-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.